This grant aims to advance translational research to better understand the emergence and worsening of mood and psychotic disorders, such as perimenopausal depression and anxiety, during the menopause transition. The primary purpose is to identify novel treatment targets by comprehending the underlying neurobiological and behavioral mechanisms. This opportunity encourages interdisciplinary collaboration to investigate various aspects, including the role of reproductive steroids, co-occurring psychiatric and menopausal symptoms, and psychosocial factors in midlife. Successful proposals will focus on hypothesis-driven work exploring the intricate interplay of these factors to improve diagnosis and develop effective interventions for women experiencing these challenges.
Opportunity ID: 329884
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-MH-21-105 |
| Funding Opportunity Title: | Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 18, 2020 |
| Last Updated Date: | Nov 18, 2020 |
| Original Closing Date for Applications: | Feb 09, 2021 |
| Current Closing Date for Applications: | Feb 09, 2021 |
| Archive Date: | Mar 17, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses State governments Independent school districts Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education For profit organizations other than small businesses Special district governments County governments Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this FOA is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effort to identity targets for future development of novel treatment interventions. This funding opportunity aims to advance novel and innovative translational research to better comprehend the underlying neurobiological and behavioral mechanisms of mood and psychosis disorders and related symptoms during MT. This funding opportunity also encourages interdisciplinary researchers to collaborate on studies of mood and psychosis during the MT. Aspects of mood and psychosis disorders that are of interest include: classic depressive symptoms in combination with menopause symptoms (e.g., hot flashes, night sweats, sleep disturbance) and psychological challenges, the role of reproductive steroids in the regulation of mood and behavior during the MT, diagnosis of mood and psychosis symptoms at menopausal stage, investigation of co-occurring psychiatric and menopause symptoms, appreciation of psychosocial factors common in midlife, and differential diagnoses. Review criteria will focus on the comprehensiveness of the neurobiology and mechanisms of action underlying mood and psychosis symptoms and hypothesis-driven work. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-105.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00264185 | Jan 09, 2021 | Feb 09, 2021 | View |
Package 1
Mandatory forms
329884 RR_SF424_2_0-2.0.pdf
329884 PHS398_CoverPageSupplement_5_0-5.0.pdf
329884 RR_OtherProjectInfo_1_4-1.4.pdf
329884 PerformanceSite_2_0-2.0.pdf
329884 RR_KeyPersonExpanded_2_0-2.0.pdf
329884 PHS398_ResearchPlan_4_0-4.0.pdf
329884 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
329884 RR_Budget_1_4-1.4.pdf
329884 RR_SubawardBudget30_1_4-1.4.pdf
329884 PHS398_ModularBudget_1_2-1.2.pdf
329884 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
